Short description
Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.
Description
Renibus Therapeutics is a clinical-stage biotech company transforming outcomes in cardiothoracic surgical patients. It has developed a portfolio of products that activate multiple cytoprotective pathways, including organ protection via preconditioning.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Southlake, Texas, United States, North America
Founded on
January 1, 2016
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess
Sign in for full access
Founders
Alvaro Guillem, D. Jeffrey Keyser